Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Investment in Endomagnetics Limited

Abstract:
UCL Business PLC, UCL's knowledge transfer and technology commercialisation company, announces that it has led an initial investment round of 350,000 into Endomagnetics Limited, a spinout company which is commercialising magnetic sensing technology arising from research within the London Centre for Nanotechnology at UCL and the Texas Centre for Superconductivity at the University of Houston. Co-investors in the investment round were the Combined London Colleges University Challenge Seed Fund ("CLCUC"), Bloomsbury Bioseed Fund ("BBSF"), together with the founders and their friends and families.

Investment in Endomagnetics Limited

London & Houston | Posted on October 1st, 2009

The company's first product is an intra-operative medical device for use in the treatment of breast cancer. Globally, 1.25 million new cases of breast cancer are diagnosed each year, whilst lifestyle changes and the availability of healthcare mean that this figure is increasing by around 20,000 cases year on year, in both the developed and the developing world. In practically all of these cases, surgery is required to remove the tumour. During the surgical procedure it is desirable to excise the sentinel lymph nodes and inspect them microscopically (i.e. perform histology) to determine whether the cancer has spread from the tumour to other sites in the body.

However, current methods of sentinel node detection present inherent and significant barriers to widespread adoption of the procedure. A key reason is that the current method is based on radiation. Locating the sentinel nodes involves injecting a radioactive dye into the lymph around the tumour. This then passes through the lymphatic system and collects in the sentinel nodes; the surgeon then uses a hand-held gamma probe to locate the node. However the use of radioisotopes presents the hospital administration with significant, and expensive, logistical burden and there is also reluctance on the part of patients to receive a radioactive injection.

Endomagnetics Ltd's approach to lymph node location radically alters the sentinel lymph node biopsy protocol. It uses a detection system based on magnetics rather than radiation, with the radioactive dye being replaced by an MRI contrast agent and a novel hand-held magnetic sensor replacing the gamma probe. This considerably simplifies the pre- and post-operative hospital procedures for sentinel lymph node biopsy, as hospitals and surgeons are freed from the constraints imposed by the use of radioactive materials during the staging procedure.

Based on 2007 cancer statistics and market research on the gamma probe market, of the 610,000 breast cancer and melanoma cases treated that year in the North America, Western Europe, Japan and Australasia, only 153,000 were addressed using the gamma-probe, indicating that there is a significant unmet need and a potential market worth at least 300 million, depending on the pricing and chosen sales model. Furthermore, the Endomagnetics solution provides a sensing platform which has applicability to other medical markets including the staging of lung, prostate and colon cancer, of which there were approximately 2,630,000 cases per annum in North America, Western Europe, Japan and Australasia in 2007.

Professor Quentin Pankhurst, Founder of Endomagnetics commented, "Endomagnetics vision is to transform the way that the staging of breast cancer is undertaken and ensure that patients across the world have access to a vital component of the breast cancer staging process. This investment will enable us to accelerate our development activity and engage with clinical adopters across the US and Europe."

Dr Steven Schooling, Director of Engineering and Physical Sciences at UCL Business said "Endomagnetics is capitalising on a innovative technology developed within the research labs of two world class research centres at UCL and Houston, which has the potential for use across a wide range of clinical conditions. UCL Business has worked closely with Professor Pankhurst and his colleagues from the initial proof of concept activities through to the raising of investment finance and we wish the team every success with their future plans."

####

About University College London
UCL (University College London) is Londons leading multidisciplinary university, with 8,000 staff and 22,000 students. Over 140 nationalities are represented among UCL students with overseas students making up nearly a third of the student body.

Based in the heart of London, UCL was the first university in England to welcome students of any class, race or religion, and the first to welcome women on equal terms with men. This same radical spirit thrives today.


We are now ranked seventh in the world by the Times Higher QS World University Rankings.

For more information, please click here

Contacts:
Tim Yates

44-020-767-99798

Copyright © Eurekalert

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016

Products

Particle Works launches range of high quality magnetic nanoparticles August 31st, 2016

Oxford Nanoimaging to provide desktop super-resolution microscopes May 10th, 2016

Abalonyx launches Reduced Graphene Oxide Product: Abalonyx has successfully scaled up production of thermally reduced graphene oxide (rGO) in its Tofte, Norway, production facility. This product is now offered to customers in Kg-quantities May 10th, 2016

New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016

Investments/IPO's/Splits

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

Nanotech Grants Options September 22nd, 2016

Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016

Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016

Nanomedicine

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Nanosensors could help determine tumors ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Announcements

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016

Alliances/Trade associations/Partnerships/Distributorships

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

PHENOMEN is a FET-Open Research Project aiming to lay the foundations a new information technology September 19th, 2016

SEMI and MSIG Join Together in Strategic Association Partnership: MEMS & Sensors Industry Group Brings New MEMS and Sensors Community to SEMI to Increase Combined Member Value September 15th, 2016

Leti and Oberthur Technologies Partner to Explore New Solutions in Fast-growing Digital Era September 12th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic